These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20058097)

  • 1. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?
    D'Hondt MA; Pottel H; Devriendt D; Van Rooy F; Vansteenkiste F
    Obes Surg; 2010 May; 20(5):595-9. PubMed ID: 20058097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study.
    Coblijn UK; Lagarde SM; de Castro SM; Kuiken SD; van Tets WF; van Wagensveld BA
    Surg Obes Relat Dis; 2016 Feb; 12(2):246-52. PubMed ID: 26381875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass.
    Rawlins L; Rawlins MP; Brown CC; Schumacher DL
    Surg Obes Relat Dis; 2013; 9(5):760-4. PubMed ID: 22951079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery.
    Cerqueira RM; Correia M; Vilar H; Manso MC
    Obes Surg; 2018 Mar; 28(3):743-747. PubMed ID: 29076008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients.
    Rasmussen JJ; Fuller W; Ali MR
    Surg Endosc; 2007 Jul; 21(7):1090-4. PubMed ID: 17514403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass.
    Schulman AR; Chan WW; Devery A; Ryan MB; Thompson CC
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):494-500.e1. PubMed ID: 27773764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey.
    Steinemann DC; Bueter M; Schiesser M; Amygdalos I; Clavien PA; Nocito A
    Obes Surg; 2014 May; 24(5):741-6. PubMed ID: 24347350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass.
    Kang X; Zurita-Macias L; Hong D; Cadeddu M; Anvari M; Gmora S
    Surg Obes Relat Dis; 2016 Jun; 12(5):1003-1007. PubMed ID: 26948448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
    Cerqueira RM; Correia MR; Vilar H; Manso MC
    Obes Surg; 2016 Jun; 26(6):1163-6. PubMed ID: 26467690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass.
    Papasavas PK; Gagné DJ; Donnelly PE; Salgado J; Urbandt JE; Burton KK; Caushaj PF
    Surg Obes Relat Dis; 2008; 4(3):383-8. PubMed ID: 17974495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass.
    Gumbs AA; Duffy AJ; Bell RL
    Surg Obes Relat Dis; 2006; 2(4):460-3. PubMed ID: 16925381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass.
    Collares-Pelizaro RVA; Santos JS; Nonino CB; dos Reis Dias LA; Gaitani CM; Salgado W
    Obes Surg; 2017 Sep; 27(9):2303-2307. PubMed ID: 28397104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years.
    Ward EK; Jensen-Otsu E; Schoen JA; Rothchild K; Mitchell B; Austin GL
    Surg Obes Relat Dis; 2015; 11(3):585-90. PubMed ID: 25553887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric stomal ulcers following Roux-en-Y gastric bypass.
    Hussain A; El-Hasani S
    Obes Surg; 2014 Dec; 24(12):2171. PubMed ID: 25160091
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of gastrogastric fistula after laparoscopic Roux-en-Y gastric bypass.
    Gumbs AA; Duffy AJ; Bell RL
    Surg Obes Relat Dis; 2006; 2(2):117-21. PubMed ID: 16925334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in Patients with Helicobacter pylori Undergoing Laparoscopic Sleeve Gastrectomy.
    Brownlee AR; Bromberg E; Roslin MS
    Obes Surg; 2015 Dec; 25(12):2276-9. PubMed ID: 26001881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Prophylactic Proton Pump Inhibitors after Roux-en-Y Gastric Bypass Surgery: A Retrospective Study.
    Plaeke P; Ruppert M; Hubens G
    Acta Chir Belg; 2015; 115(4):273-8. PubMed ID: 26324028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: A national survey of surgeon practices.
    Giannopoulos S; Athanasiadis DI; Clapp B; Lyo V; Ghanem O; Puzziferri N; Stefanidis D;
    Surg Obes Relat Dis; 2023 Apr; 19(4):303-308. PubMed ID: 36379840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study.
    Garrido AB; Rossi M; Lima SE; Brenner AS; Gomes CA
    Arq Gastroenterol; 2010; 47(2):130-4. PubMed ID: 20721455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.